6505NCM206473: ADALIMUMAB INJECTION.
The ADALIMUMAB INJECTION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: ADALIMUMAB INJECTION, 40 MG/0.8 ML. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-691-4533, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | ADALIMUMAB INJECTION, 40 MG/0.8 ML |
| NSN | 6505-01-691-4533 |
| SPECIAL FEATURES | HUMIRA IS A TISSUE NECROSIS FACTOR (TNF) BLOCKER INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS TO REDUCE THE SIGNS AND SYMPTOMS INDUCING MAJOR CLINICAL RESPONSE, INHIBITING THE PROGRESSION OF STRUCTURAL DAMAGE, AND IMPROVING PHYSICAL FUNCTION IN ADULT PATIENTS; HUMIRA IS SUPPLIED IN A CARTON CONTAINING A 1 ML PREFILLED GLASS SYRINGE WITH A FIXED 1/2 INCH NEEDLE, PROVIDING 40 MG/0.8 ML OF HUMIRA; THE NEEDLE COVER MAY CONTAIN NATURAL RUBBER LATEX; INTENDED FOR SUBCUTANEOUS ADMINISTRATION; DO NOT USE BEYOND THE EXPIRATION DATE ON THE CONTAINER; HUMIRA MUST BE REFRIGERATED AT 36 F TO 46 F (2 C TO 8 C); DO NOT FREEZE; DO NOT USE IF FROZEN EVEN IF IT HAS BEEN THAWED. IN |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ADALIMUMAB INJECTION, 40 MG/0.8 ML |